Intravenous Ketamine for Treatment-Resistant Depression

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Intravenous Ketamine for Treatment-Resistant Depression	Depressive Disorder, Treatment-Resistant, depressive disorder, major depressive disorder, mood disorder, psychiatric disorder	Recruiting	Phase 2	2025-10-14		NCT06668571

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Mayo Clinic	970
National Center for Advancing Translational Sciences (NCATS)	127

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Mayo Clinic in Rochester	Rochester	United States	687

Clinical trials